FRTX logo

FRTX Revenue

Annual Revenue

$8.01 M
+$1.06 M+15.31%

December 31, 2023

Summary

Performance

1-Year Change

+15.31%

3-Year Change

+339.41%

5-Year Change

+393.59%

15-Year Change

-42.07%

FRTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.88%
FRTX annual revenue is higher than 27.88% of companies in Healthcare sector

Analysts Estimate

$6.00 M
FRTX annual revenue is currently +33.43% higher than the consensus analysts' forecast

High & Low

All-time High

$30.02 M
FRTX annual revenue is currently -73.33% below its historical high of $30.02 million

3-Year Low

$404.00 K
FRTX annual revenue is currently +1881.68% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FRTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
FRTX next annual earnings announcement is scheduled for May 15, 2025

OtherFRTXprofitabilitymetrics:

Annual EPS

-$1.06
FRTX annual earnings per share is -$1.06

Annual Net Income

-$5.69 M
FRTX annual net profit is -$5.69 million

Annual Operating Profit

-$6.36 M
FRTX annual operating income is -$6.36 million

Annual Gross Profit

-
FRTX annual gross profit value is unknown

Quarterly Revenue

N/A

December 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

FRTX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$500.00 K
FRTX quarterly revenue is currently equal to the consensus analysts' forecast

High & Low

All-time High

$26.62 M
FRTX quarterly revenue is currently at an all-time high

3-Year Low

$9000.00
FRTX quarterly revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
FRTX previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

May 15, 2025
FRTX next earnings announcement is scheduled for May 15, 2025

Related metrics

Quarterly Gross Profit

-
FRTX quarterly gross profit value is unknown

Quarterly Operating Profit

-$1.65 M
FRTX quarterly operating income is -$1.65 million

Quarterly Net Income

-$1.24 M
FRTX quarterly net profit is -$1.24 million

Quarterly EPS

-$0.20
FRTX quarterly earnings per share is -$0.20

TTM Revenue

N/A

December 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

FRTX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$8.50 M
FRTX TTM revenue is currently equal to the consensus analysts' forecast

High & Low

All-time High

$41.58 M
FRTX TTM revenue is currently at an all-time high

3-Year Low

$404.00 K
FRTX TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
FRTX previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

May 15, 2025
FRTX next earnings announcement is scheduled for May 15, 2025

OtherFRTXprofitabilitymetrics:

TTM Gross Profit

-
FRTX TTM gross profit value is unknown

TTM Operating Profit

-$6.36 M
FRTX TTM operating income is -$6.36 million

TTM Net Income

-$5.69 M
FRTX TTM net profit is -$5.69 million

TTM EPS

-$1.41
FRTX TTM earnings per share is -$1.41

FRTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.3%--
3 y3 years+339.4%--
5 y5 years+393.6%--

FRTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+1881.7%
5 y5-yearat high+1881.7%
alltimeall time-73.3%+1881.7%

Fresh Tracks Therapeutics Revenue History

DateAnnualQuarterlyTTM
Dec 2023
$8.01 M(+15.3%)
-
-
Sep 2023
-
$7.94 M(>+9900.0%)
$10.06 M(+287.1%)
Jun 2023
-
$53.00 K(+488.9%)
$2.60 M(-62.1%)
Mar 2023
-
$9000.00(-99.6%)
$6.86 M(-1.2%)
Dec 2022
$6.94 M(+1618.6%)
$2.05 M(+321.8%)
$6.94 M(+38.9%)
Sep 2022
-
$486.00 K(-88.7%)
$5.00 M(+7.6%)
Jun 2022
-
$4.32 M(+4590.2%)
$4.64 M(+869.3%)
Mar 2022
-
$92.00 K(-11.5%)
$479.00 K(+18.6%)
Dec 2021
$404.00 K(-77.8%)
-
-
Dec 2021
-
$104.00 K(-21.2%)
$404.00 K(+23.5%)
Sep 2021
-
$132.00 K(-12.6%)
$327.00 K(-3.0%)
Jun 2021
-
$151.00 K(+788.2%)
$337.00 K(-57.5%)
Mar 2021
-
$17.00 K(-37.0%)
$793.00 K(-56.5%)
Dec 2020
$1.82 M(-77.0%)
$27.00 K(-81.0%)
$1.82 M(-26.1%)
Sep 2020
-
$142.00 K(-76.6%)
$2.46 M(-29.7%)
Jun 2020
-
$607.00 K(-42.0%)
$3.50 M(+20.9%)
Mar 2020
-
$1.05 M(+56.4%)
$2.90 M(-45.8%)
Dec 2019
$7.92 M(+388.1%)
$669.00 K(-43.4%)
$5.34 M(+11.4%)
Sep 2019
-
$1.18 M(-66.1%)
$4.80 M(+9.1%)
Mar 2019
-
$3.49 M(+2716.1%)
$4.40 M(+171.1%)
Dec 2018
$1.62 M(-88.3%)
$124.00 K(+163.8%)
$1.62 M(-70.2%)
Sep 2018
-
$47.00 K(-93.6%)
$5.45 M(-36.9%)
Jun 2018
-
$735.00 K(+2.7%)
$8.64 M(-23.7%)
Mar 2018
-
$716.00 K(-81.9%)
$11.33 M(-18.0%)
Dec 2017
$13.82 M(-4.9%)
$3.95 M(+22.0%)
$13.82 M(+6.1%)
Sep 2017
-
$3.24 M(-5.3%)
$13.03 M(+4.8%)
Jun 2017
-
$3.42 M(+6.7%)
$12.43 M(-5.3%)
Mar 2017
-
$3.21 M(+1.3%)
$13.13 M(-9.6%)
Dec 2016
$14.53 M(-30.6%)
$3.16 M(+19.7%)
$14.53 M(-20.1%)
Sep 2016
-
$2.64 M(-35.9%)
$18.18 M(-11.6%)
Jun 2016
-
$4.12 M(-10.5%)
$20.56 M(-0.3%)
Mar 2016
-
$4.60 M(-32.4%)
$20.61 M(-1.6%)
Dec 2015
$20.95 M(+37.7%)
$6.81 M(+35.8%)
$20.95 M(+10.5%)
Sep 2015
-
$5.02 M(+20.1%)
$18.96 M(+9.1%)
Jun 2015
-
$4.18 M(-15.5%)
$17.39 M(-1.9%)
Mar 2015
-
$4.94 M(+2.5%)
$17.71 M(+16.4%)
Dec 2014
$15.22 M(+97.2%)
$4.82 M(+40.1%)
$15.22 M(+12.4%)
Sep 2014
-
$3.44 M(-23.6%)
$13.54 M(+16.3%)
Jun 2014
-
$4.50 M(+84.1%)
$11.64 M(+35.5%)
Mar 2014
-
$2.45 M(-22.2%)
$8.59 M(+11.3%)
Dec 2013
$7.72 M(-55.9%)
$3.15 M(+103.8%)
$7.72 M(+12.0%)
Sep 2013
-
$1.54 M(+6.0%)
$6.89 M(-8.4%)
Jun 2013
-
$1.46 M(-7.5%)
$7.52 M(-1.4%)
Mar 2013
-
$1.57 M(-32.1%)
$7.63 M(-56.4%)
Dec 2012
$17.52 M(-41.6%)
$2.32 M(+6.6%)
$17.52 M(+2.3%)
Sep 2012
-
$2.17 M(+39.0%)
$17.13 M(-58.8%)
Jun 2012
-
$1.56 M(-86.3%)
$41.58 M(+1.8%)
Mar 2012
-
$11.46 M(+493.2%)
$40.83 M(+36.0%)
Dec 2011
$30.02 M(+244.6%)
$1.93 M(-92.7%)
$30.02 M(-3.2%)
Sep 2011
-
$26.62 M(+3154.2%)
$31.00 M(+366.9%)
Jun 2011
-
$818.00 K(+26.0%)
$6.64 M(-15.9%)
Mar 2011
-
$649.00 K(-77.7%)
$7.90 M(-9.3%)
Dec 2010
$8.71 M(-31.3%)
$2.92 M(+29.2%)
$8.71 M(+4.3%)
Sep 2010
-
$2.26 M(+8.8%)
$8.35 M(-16.5%)
Jun 2010
-
$2.08 M(+41.8%)
$10.00 M(-16.0%)
Mar 2010
-
$1.46 M(-42.7%)
$11.90 M(-6.2%)
Dec 2009
$12.69 M(+59.5%)
$2.56 M(-34.5%)
$12.69 M(-0.5%)
Sep 2009
-
$3.90 M(-1.9%)
$12.76 M(+31.5%)
Jun 2009
-
$3.98 M(+76.8%)
$9.70 M(+17.3%)
Mar 2009
-
$2.25 M(-14.3%)
$8.27 M(+3.9%)
Dec 2008
$7.96 M(+44.3%)
$2.63 M(+211.0%)
$7.96 M(+30.4%)
Sep 2008
-
$844.00 K(-66.9%)
$6.10 M(+8.3%)
Jun 2008
-
$2.55 M(+31.3%)
$5.63 M(-9.1%)
Mar 2008
-
$1.94 M(+151.6%)
$6.20 M(+12.4%)
Dec 2007
$5.51 M(-62.6%)
$771.00 K(+105.6%)
$5.51 M(-8.8%)
Sep 2007
-
$375.00 K(-87.9%)
$6.04 M(-3.1%)
Jun 2007
-
$3.11 M(+147.9%)
$6.24 M(-39.9%)
Mar 2007
-
$1.25 M(-3.7%)
$10.38 M(-29.6%)
DateAnnualQuarterlyTTM
Dec 2006
$14.74 M(+22.8%)
$1.30 M(+130.2%)
$14.74 M(-3.3%)
Sep 2006
-
$566.00 K(-92.2%)
$15.24 M(-12.3%)
Jun 2006
-
$7.26 M(+29.2%)
$17.38 M(+16.4%)
Mar 2006
-
$5.62 M(+211.1%)
$14.93 M(+24.4%)
Dec 2005
$12.00 M(-17.5%)
$1.80 M(-33.3%)
$12.00 M(-21.0%)
Sep 2005
-
$2.71 M(-43.7%)
$15.20 M(-1.2%)
Jun 2005
-
$4.81 M(+79.1%)
$15.38 M(-5.7%)
Mar 2005
-
$2.68 M(-46.4%)
$16.32 M(+12.2%)
Dec 2004
$14.54 M(+80.1%)
$5.00 M(+73.1%)
$14.54 M(+29.4%)
Sep 2004
-
$2.89 M(-49.6%)
$11.24 M(-15.0%)
Jun 2004
-
$5.74 M(+531.6%)
$13.22 M(+63.6%)
Mar 2004
-
$909.00 K(-46.4%)
$8.08 M(+0.0%)
Dec 2003
$8.08 M(+15.3%)
$1.70 M(-65.2%)
$8.08 M(+16.9%)
Sep 2003
-
$4.87 M(+710.6%)
$6.91 M(+51.6%)
Jun 2003
-
$601.20 K(-33.8%)
$4.56 M(-28.8%)
Mar 2003
-
$908.30 K(+72.0%)
$6.40 M(-8.6%)
Dec 2002
$7.01 M(-38.4%)
$528.00 K(-79.0%)
$7.01 M(-37.7%)
Sep 2002
-
$2.52 M(+3.0%)
$11.25 M(+1.2%)
Jun 2002
-
$2.45 M(+62.0%)
$11.12 M(+6.4%)
Mar 2002
-
$1.51 M(-68.3%)
$10.45 M(-8.1%)
Dec 2001
$11.37 M(+49.2%)
$4.77 M(+100.0%)
$11.37 M(+34.1%)
Sep 2001
-
$2.39 M(+34.2%)
$8.47 M(+10.0%)
Jun 2001
-
$1.78 M(-26.9%)
$7.70 M(-13.2%)
Mar 2001
-
$2.43 M(+29.5%)
$8.87 M(+19.3%)
Dec 2000
$7.62 M(-28.8%)
$1.88 M(+16.5%)
$7.44 M(-29.1%)
Sep 2000
-
$1.61 M(-45.3%)
$10.50 M(+3.8%)
Jun 2000
-
$2.95 M(+195.4%)
$10.11 M(+20.1%)
Mar 2000
-
$997.70 K(-79.8%)
$8.42 M(-21.5%)
Dec 1999
$10.70 M(+81.4%)
$4.94 M(+301.8%)
$10.72 M(+60.4%)
Sep 1999
-
$1.23 M(-2.0%)
$6.68 M(-6.6%)
Jun 1999
-
$1.25 M(-62.0%)
$7.15 M(+10.1%)
Mar 1999
-
$3.30 M(+266.7%)
$6.50 M(+10.2%)
Dec 1998
$5.90 M(-24.4%)
$900.00 K(-47.1%)
$5.90 M(-19.2%)
Sep 1998
-
$1.70 M(+183.3%)
$7.30 M(-19.8%)
Jun 1998
-
$600.00 K(-77.8%)
$9.10 M(-3.2%)
Mar 1998
-
$2.70 M(+17.4%)
$9.40 M(+20.5%)
Dec 1997
$7.80 M(+16.4%)
$2.30 M(-34.3%)
$7.80 M(+2.6%)
Sep 1997
-
$3.50 M(+288.9%)
$7.60 M(+65.2%)
Jun 1997
-
$900.00 K(-18.2%)
$4.60 M(-37.0%)
Mar 1997
-
$1.10 M(-47.6%)
$7.30 M(+9.0%)
Dec 1996
$6.70 M(+6.3%)
$2.10 M(+320.0%)
$6.70 M(+26.4%)
Sep 1996
-
$500.00 K(-86.1%)
$5.30 M(-11.7%)
Jun 1996
-
$3.60 M(+620.0%)
$6.00 M(+1.7%)
Mar 1996
-
$500.00 K(-28.6%)
$5.90 M(-7.8%)
Dec 1995
$6.30 M(+14.5%)
$700.00 K(-41.7%)
$6.40 M(+1.6%)
Sep 1995
-
$1.20 M(-65.7%)
$6.30 M(-4.5%)
Jun 1995
-
$3.50 M(+250.0%)
$6.60 M(+22.2%)
Mar 1995
-
$1.00 M(+66.7%)
$5.40 M(0.0%)
Dec 1994
$5.50 M(-8.3%)
$600.00 K(-60.0%)
$5.40 M(-5.3%)
Sep 1994
-
$1.50 M(-34.8%)
$5.70 M(+18.8%)
Jun 1994
-
$2.30 M(+130.0%)
$4.80 M(+45.5%)
Mar 1994
-
$1.00 M(+11.1%)
$3.30 M(-45.0%)
Dec 1993
$6.00 M(+66.7%)
$900.00 K(+50.0%)
$6.00 M(0.0%)
Sep 1993
-
$600.00 K(-25.0%)
$6.00 M(-4.8%)
Jun 1993
-
$800.00 K(-78.4%)
$6.30 M(-1.6%)
Mar 1993
-
$3.70 M(+311.1%)
$6.40 M(+77.8%)
Dec 1992
$3.60 M(+50.0%)
$900.00 K(0.0%)
$3.60 M(+9.1%)
Sep 1992
-
$900.00 K(0.0%)
$3.30 M(+10.0%)
Jun 1992
-
$900.00 K(0.0%)
$3.00 M(+11.1%)
Mar 1992
-
$900.00 K(+50.0%)
$2.70 M(+12.5%)
Dec 1991
$2.40 M(+33.3%)
$600.00 K(0.0%)
$2.40 M(+4.3%)
Sep 1991
-
$600.00 K(0.0%)
$2.30 M(+4.5%)
Jun 1991
-
$600.00 K(0.0%)
$2.20 M(+10.0%)
Mar 1991
-
$600.00 K(+20.0%)
$2.00 M(+11.1%)
Dec 1990
$1.80 M
$500.00 K(0.0%)
$1.80 M(+38.5%)
Sep 1990
-
$500.00 K(+25.0%)
$1.30 M(+62.5%)
Jun 1990
-
$400.00 K(0.0%)
$800.00 K(+100.0%)
Mar 1990
-
$400.00 K
$400.00 K

FAQ

  • What is Fresh Tracks Therapeutics annual revenue?
  • What is the all time high annual revenue for Fresh Tracks Therapeutics?
  • What is Fresh Tracks Therapeutics annual revenue year-on-year change?
  • What is the all time high quarterly revenue for Fresh Tracks Therapeutics?
  • What is the all time high TTM revenue for Fresh Tracks Therapeutics?

What is Fresh Tracks Therapeutics annual revenue?

The current annual revenue of FRTX is $8.01 M

What is the all time high annual revenue for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high annual revenue is $30.02 M

What is Fresh Tracks Therapeutics annual revenue year-on-year change?

Over the past year, FRTX annual revenue has changed by +$1.06 M (+15.31%)

What is the all time high quarterly revenue for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high quarterly revenue is $26.62 M

What is the all time high TTM revenue for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high TTM revenue is $41.58 M